论文部分内容阅读
资料显示,脑卒中是导致人类死亡和残疾的首要疾病。我国每年新发脑卒中病例有195万,死亡156万,存活者中半数有不同程度的残疾。新发病人直接医疗费高达100亿元人民币,给我国经济造成非常沉重的负担。脑卒中患者一般应用溶栓治疗,但由于严格的适应证和医疗条件的限制,目前一些治疗方法如急性期溶栓仅能满足极少数患者的需要。因此,研发适合广大脑卒中患者更有效的治疗方法,成为21世纪全世界神经科学研究的重点。本专辑选译自《medicina》第43卷第2期“ブレインアタック2006——t-PA?代の診断と治?”专辑,希望能够对神经科医生在进行临床溶栓治疗时有所帮助。本专辑由中国医科大学附属第一医院神经内科陈谅教授审校。
Data show that stroke is the leading cause of death and disability in humans. In our country, there are 1.95 million new stroke cases each year, with a death rate of 1.56 million. Half of the survivors have disability in varying degrees. The new direct medical expenses as high as 10 billion yuan, to our economy caused a very heavy burden. Stroke patients generally use thrombolytic therapy, but due to strict indications and medical conditions, some of the current treatment methods such as acute thrombolysis can only meet the needs of very few patients. Therefore, research and development of more effective treatment for stroke patients in the 21st century become the focus of neuroscience research in the world. The album is selected from the “medicina” Volume 43, No. 2 “Brite イ ン ア ッ ク 2006 - t-PA generation of diagnosis and treatment” album, hoping to neurologists in the clinical thrombolytic therapy helpful. The album by the China Medical University Affiliated Hospital of Neurology, Professor Chen Xing review.